New patent for Clarus drug JATENZO June 4, 2022 Comments Off on New patent for Clarus drug JATENZO Posted in: General BiotechnologyAnnual Drug Patent Expirations for JATENZO Jatenzo is a drug marketed by Clarus and is included in one NDA. It is available from one supplier. There…
Source: www.biotechblog.com – Read more

400+ SAP NetWeaver Devices Vulnerable to 0-Day Attacks that Exploited in the Wild
Shadow Servers have identified 454 vulnerable SAP NetWeaver systems affected by a critical zero-day flaw, CVE-2025-31324, allowing unauthenticated file uploads and potential system compromise. Discovered